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Background and Aims: Familial Mediterranean fever (FMF) is a prototype of autoin-
flammatory disease and mainly associated with MEFV gene mutations. This single-center
study as an experience represents FMF-coexisting disease in the FMF registration database.
Methods: Four hundred patients who had FMF based on clinical criteria (Tel-Hashomer)
and/or MEFV mutations enrolled the study. Twelve most common MEFV mutations (P369S,
F479L, M680I (G/C), M680I (G/A), I692del, M694V, M694I, K695R, V726A, A744S,
R761H, E148Q) were analyzed if needed by the reverse hybridization assay. Any co-
existed disease had been confirmed by a related subspecialist. All data were analyzed by
a simple analytical method.
Results: Fifty-seven (14%) patients had associated disease, 32 patients were male and 24
patients were under 10 years old. They included 92 MEFV variant alleles and only in five
patients there were not any mutations. The most common variant alleles were M694V (36%),
E148Q (22%), V726A (17%), M680I (1%) and M694I (0.07%) respectively. Rheumatologic
disorders were the most common coexisting disease, then followed by gastrointestinal and
neurological disorders. Some rare diseases such as TTP, growth hormone deficiency, multiple
sclerosis, idiopathic ascites, Leiden factor V deficiency and Felty syndrome have been
detected. Homozygote mutations of (M694V-M694V) were associated with idiopathic ascites,
orchitis and pericarditis.
Conclusion: Coexisting disease in patients with FMF is presented with positive MEFV gene
mutations particularly with these five common variant alleles: M694V, E148Q, V726A,
M680I, and M694I. The commonly associated diseases are rheumatologic, gastrointestinal
and CNS disorders.
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Introduction
FMF is an autoinflammatory and autosomal recessive disease mainly affecting
ethnic groups living around the Mediterranean Sea: Jews, Armenians, Turks,
Arabs,1 with a prevalence ranging from 1/200 to 1/1000.2
Early manifestations have usually appeared by the first decade and are char-
acterized by recurrent, self-limiting attacks of polyserositis and fever. Serositis is
presented by abdominal and chest pain as peritonitis or pleuritis, and, with less
frequency pericarditis and recurrent painful orchitis can be seen.3
Arthritis in periodic and nondestructive form or persistent with chronic destruc-
tive pattern usually in large joints may occur. Severe prolonged myalgia or myositis
due to vasculitis is seen.4,5 Frequency of attacks is variable and asymptomatic periods
that last also a few years have been reported. Laboratory evaluation shows positive
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results of acute-phase reactant that may be detected more-
over in asymptomatic periods, particularly serum amy-
loid A.6,7
Until 1998, the diagnosis of FMF was based on clinical
criteria alone. The Tel Hashomer criteria generally form
the basis of the clinical diagnosis. These criteria contain
three major (recurrent febrile episodes accompanied by
serositis; amyloidosis of AA type; favorable response to
colchicine) and three minor criteria (FMF in first-degree
relatives; erysiplase like erythema; recurrent febrile epi-
sodes); for diagnosis of FMF, it needs two major or one
major plus two minor criteria.8 In 1992, the gene respon-
sible for FMF, (MEDITERRANEAN FEVER)MEFV, was
found on the short arm of chromosome 16.9 Five years
later, the MEFV gene locus was discovered that encode the
protein named marenostrin or pyrin.10 This protein prob-
ably has an important role in the downregulation of
inflammation in innate immune response.
In populations with a high FMF, prevalence clinical
criteria have a high specificity of 95–99% for the presence
of genetically confirmed FMF, but sensitivity is much
lower. In a recent study, FMF was genetically confirmed
in 60% of patients who fulfilled clinical criteria in
Mediterranean origin,11 while it was much lower in
patients from non-Mediterranean areas (10%).12
Although until the last decade, the MEFV gene was
considered to be responsible only for FMF; however, it is
now known that it can also be associated with other
clinical conditions with a main effect on the course and
severity of the disease.13
Coexistence of FMF with rheumatoid and autoimmune
conditions like seronegative spondyloarthropathy (SpA)14
Bechet’s disease15 rheumatoid arthritis (RA)16 Sjögren’s
syndrome.17 Juvenile idiopathic arthritis,18,19 inflamma-
tory bowel disease (IBD)20 and polyarteritis nodosa
(PAN)21 have been reported.
In this study, we aimed to evaluate the frequency of
comorbid disorders in a large FMF cohort of FMF registra-
tion center with relatively long follow-up duration.
Additionally, we aimed to assess the association between
FMF and other co-existed diseases and conditions with gen-
otype-phenotype correlation survey. (WWW.FMFIRAN.IR)
Methods
Study Population
This is a case series study. The data of 400 FMF patients,
who were diagnosed based on Tel- Hashomer criteria at
the rheumatologic clinics of Bouali Hospital and from
FMF Registration Center database (http://www.fmfiran.ir)
were collected.
Demographic information of patients, such as age,
race, gender, and their extra FMF disease, which have
been confirmed by adult or pediatric subspecialist were
collected.
MEFG Gene Analysis Study
Blood samples were screened for the 12 common pathogenic
variants (E148Q, P369S, F479L, I692del, M680I (G/C),
M680I (G/A), M694V, M694I, K695R, V726A, A 744S
and R 761H) according to manufacturer’s instructions
(FMF Strip Assay, Vienna lab, Vienna, Austria). The study
is complaint with the Helsinki Declaration and was approved
by the local Ethics.
Ethical and Legal Aspect
Committee under number IR.ARUMS. REC.1396.95.
Written Informed consent was obtained from all the parti-
cipants and/or their parents.
Comorbidity Diagnosis
Among them, 57 patients had associated disease that had
been confirmed by related subspecialist and clinic of the
hospital.
Statistical Analysis
Analysis was mainly descriptive, we have done all the
statistical analyses with IBM SPSS 20 program (SPSS
Inc., Chicago, IL, USA). Categorical variables were
reported as numbers and percentages. Fisher’s exact
test was used when the sample size was small (expected
cell sizes < 5). The statistical significance defined as
p value <0.05.
Results
Among the patients, 57 (14%) had associated disease other
than FMF manifestations. Thirty-two patients were male and
24 patients were under 10 years old. Tables 1 and 2 show the
patient’s profile as inflammatory and non-inflammatory
conditions.
There were 92 MEFV gene mutations. The most
common were M694V (36%), E148Q (22%), V726A
(17%), M680I (1%) and M694I (0.07%), respectively,
and other mutations (R761H, P369S, A744S, M694L,
R202Q) were the rest. Rheumatologic disorders were
the most common co-exist disease (Arthritis, PFAPA,
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Vasculitis), followed by gastrointestinal GI (Peptic ulcer,
cholelithiasis) and CNS (migraine, seizure) disorder.
Some rare diseases such as thrombotic thrombocytopenic
purpura TTP, growth hormone deficiency, multiple sclero-
sis MS, ascites and Leiden factor V deficiency and
retinitis pigmentosa have been shown. JIA had M680I-
V726A mutations and in RA M694V-M680I or V726A
mutations have been shown. These homozygote muta-
tions (M694V-M694V) were associated with idiopathic
ascites, orchitis and pericarditis. There were three cases
of JSpA and one case of Felty syndrome and one patient
with childhood PAN. There was not a meaningful asso-
ciation between MEFV mutations and non-inflammatory
disease. (P value 0.05%)
Table 1 Autoinflammatory and Autoimmune Disorders Co-
Existed
No. Age Sex MEFV Gen.
Mutations
Co-Exist Condition
Autoinflammatory conditions
1 7 M M680I-Wt (?) PFAPA
2 18 M M694V- Wt (?) PFAPA
3 6 F M694V- Wt (?) PFAPA
4 5 F E148Q- Wt (?) PFAPA
5 9 F V726A -Wt (?) PFAPA
6 11 M R761H-M694I PFAPA
Inflammatory joints disease
7 14 F M680I- V726A JIA (Oligo A.)
8 45 M M680I- M694V RA
9 16 F M680I- V726A JIA (Oligo A.)
10 19 F M694V- V726A RA
11 15 F Wt/Wt PAN
12 40 M M694V- M694V RA+ Felty syndrome
13 14 M M694V-R202Q JSpA
14 14 M M694V- M694V JSpA
15 4 M M694V-R202Q JSpA
Organic-specific autoimmune disease
16 7 F E148Q-V726A (IBD) Ulcerative colitis
17 38 M M680I-Wt (?) (IBD) Crohn Disease
18 10 M Wt (?)-Wt (?) Alopecia totalis
19 37 F Wt (?)-Wt (?) Multiple Sclerosis (MS)
20 11 M E148Q-P369S Celiac
21 21 M R761H-V726A TTP (Thrombotic
Thrombocytopenic Purpura)
Systemic vasculitis
22 5 F E148Q- Wt (?) (IgAV) Henoch–Schönlein
purpura
23 7 F E148Q-V726A Bechet Disease
24 29 M M694V- E148Q Protracted febrile myalgia
syndrome (PFMS)
25 20 M M680I-V726A (IgAV) Henoch–Schönlein
purpura
Non-clarified associated serositis
26 12 M M694V- V726A Pleuritis (Recurrent Idiopathic/
FMF related)
27 13 M M694V- M694V Pericarditis (Recurrent
Idiopathic/FMF related)
28 49 F M694V-M694V Ascites (Idiopathic/FMF related)
29 46 F M694V-M694V Ascites (Idiopathic/FMF related)
30 23 M M694V-M694V Orchitis (Idiopathic recurrent/
FMF related)
Table 2 Non-Inflammatory Coexisting Disorders
No. Age Sex MEFV Gen.
Mutations
Co-Exist Condition
Hematologic, hormonal, metabolic conditions
26 12 F E148Q- Wt (?) Thalassemia
27 8 F E148Q-M694V Thalassemia
28 43 M Wt (?)-Wt (?) Hyperlipidemia
29 45 F M694V- Wt (?) Infertility (Idiopathic)
30 9 F M694V-M680I Growth hormone
deficiency
31 45 M M680I- M694V LIDEN Factor
Deficiency
32 21 M R761H-V726A Pancytopenia
33 41 F E148Q- V726A Hypothyroidism
(Idiopathic)
34 25 F M694L-R202Q Retinitis pigmentosa
Common non-inflammatory disease/conditions
35 22 F E148Q- P369S Peptic Ulcer Disease
36 8 F E148Q-M694V Peptic Ulcer Disease
37 41 M Wt (?)- Wt (?) Peptic Ulcer Disease
38 13 M Wt (?)- Wt (?) Peptic Ulcer Disease
39 47 F M694I- V726A Peptic Ulcer Disease
40 10 F E148Q- P369S Cholelithiasis
41 9 M E148Q- P369S Cholelithiasis
42 11 M M694I- M694I Cholelithiasis
43 7 M M680I- V726A Cholelithiasis
44 12 F E148Q- Wt (?) Migraine
45 8 F A744S- Wt (?) Migraine
46 11 M E148Q- Wt (?) Migraine
47 15 F M694V- Wt (?) Seizure (idiopathic)
48 11 M R761H-M694I Seizure (idiopathic)
49 8 M M694V- V726A Seizure (idiopathic)
50 5 M E148Q-A744S Vesicoureteral Reflux
51 5 M E148Q-A744S Gastroesophageal
Reflux
52 12 F E148Q- Wt (?) Congenital Cardiac
Anomaly
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Discussion
Vasculitis
Vasculitis is found at a higher incidence in FMF patients
than in the unaffected population.13 In our series, we had
just two cases of IgA-V (0.5%) with positive MEFV muta-
tions, while HSP has been reported in 3% even to 11% of
FMF patients. Occult FMF cases were identified from
Israel, commonly in children with IgA-V.22
PAN also occurs more commonly in patients with FMF
usually with a younger age of onset.23 We detected one
case of PAN among the patients however with negative
MEFV mutations. The prevalence of PAN in FMF patients
is about 1% (24) Hypertension and nephritis are more
likely to occur in PAN than in FMF-PAN patients25 it
seems that PAN is less severe in FMF patients.26 In
patients with PAN-FMF, the prevalence of antistreptolysin
O antibody elevation is high27.Data are insufficient to
determine whether this disorder is more common in FMF
patients than in the general population.28
Arthritis
We had two cases of JIA with Oligo-type and same muta-
tions (M680I-V726A) in both and two cases of RA which
showed combined heterozygote mutations. This collection
contains three cases of Juvenile Spondylo-Arthropathy
(JSpA) and one case of RA with neutropenia as a Felty
syndrome; in our knowledge FMF association with Felty
syndrome has not been reported already. Recurrent mono-
arthritis can be the sole manifestation of FMF; in such
cases, the true diagnosis may not be established for some
time. Lidar et al conducted a study to clinically and
genetically characterize patients with FMF in whom arthri-
tis constituted the only manifestation of FMF. The authors
concluded those FMF groups were febrile with short dura-
tion arthritis, positive family history of FMF and MEFV
mutations with good response to colchicine.29 We reported
a rare form of relapsing arthritis as palindromic rheuma-
tism that had been related to MEFV gene mutations with-
out apparent FMF manifestation.30
Serositis
In our study, there was a patient with recurrent febrile
chest pain as the only manifestation of FMF and combined
MEFV mutations (M694V-V726A). Pleuritis can rarely
present as the sole manifestation of FMF. As a rule in
patients with paroxysmal febrile chest pain, especially in
the Mediterranean area, FMF should be considered.3
Recurrent pericarditis, though rare, can present as the
single manifestation of FMF. Okutur et al described
a 25-year-old Turkish woman who presented with recur-
rent pericarditis of no obvious cause.31 In our series,
there was one case with the same problem and M694V-
M694V mutation analysis.
Skin Disease
In our series, there was not any especial skin disease
except a case of alopecia totalis without MEFV gene
mutation, but recurrent urticarial has been reported as
a rare manifestation of FMF. Alonso et al described
a patient with recurrent urticarial and final diagnosis of
FMF.32
Neurological Disease
Neurological involvement has been reported and it varies
from headache to aseptic meningitis. Meningitis can occur
rarely in FMF as Mollaret meningitis. In each of the
reported cases, the patients’ attacks of recurrent aseptic
meningitis resolved after treatment with colchicine.33–35
We reported recently neurological manifestation of famil-
ial Mediterranean fever as a separate study.36 FMF-
associated central nervous system (CNS) involvement
includes demyelinating lesions, stroke, and posterior rever-
sible leukoencephalopathy syndrome (PRES). Different
studies showed that MS patients with MEFV mutations
seem to develop a more progressive disease and it seems
that MEFV mutations may increase the risk of MS
progression.37–39
Inflammatory Disorder
In this work, there is a Bechet child with E148Q-V726A
mutation analysis. An increased frequency of MEFV muta-
tions has been reported in individuals with Bechet disease.
FMF carriers with Bechet disease have been found to have
an increased risk for venous thrombosis.40 Both FMF and
Bechet disease are observed all around the Mediterranean
area. From different studies,41–43 BD patients have
a higher frequency of MEFV mutations than controls,
and this high prevalence provides a further argument to
support the role of MEFV mutations in the manifestation
of different inflammatory disorders other than FMF.44
This study contains two cases of IBD with E148Q-
V726A mutations as Ulcerative Colitis (UC) and M680I-
Wt (?) in Crohn disease (CD). Some studies have found an
increased frequency of MEFV mutations in patients with
UC.20 Other studies have found that CD seems to be more
Salehzadeh and Enteshari Moghaddam Dovepress
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prevalent in FMF patients.45,46 MEFV gene mutations may
act as modifiers and affecting the expression of IBD.13
Patients with FMF certainly have an exaggerated
response to streptococcal antigens and may be more prone
to the late complications of streptococcal infection.20
Although there was not any cases in our patients,
Streptococcus-associated diseases with the presence of high
levels of antistreptolysin O (ASO) antibodies and streptococ-
cus-associated diseases, such as acute poststreptococcal glo-
merulonephritis and acute rheumatoid fever, have been
reported in patients with FMF.47
Non-Inflammatory Diseases
In this work, there were four cases of peptic ulcer disease
(PUD) and four patients with cholelithiasis (CL), which in
most of them there were combined heterozygote mutations
(Table 2).
Here, we represent a patient with celiac disease coex-
isted with FMF and E148Q-P369S mutations. FMF and
celiac disease (CD) may show different genetic and envir-
onmental factors as well as certain clinical features;48
however, the association between CD and FMF remains
controversial.
Two sisters had idiopathic ascites and FMF with homo-
zygote mutations as M694V-M694V. A female patient
with FMF who developed chronic ascites has been
reported by Ureten et al. She was a compound heterozy-
gote for the mutations M694V and M680I, and after dose
adjustment of colchicine, the amount of ascites
decreased.49 There was one patient with recurrent orchitis
and M694V-M694V mutations, although acute scrotum is
rarely seen as a complication of FMF.50
Miscellaneous Disorder
Patients with growth hormone deficiency, TTP, Leiden
Factor deficiency and retinitis pigmentosa and Felty syn-
drome were additional and probably unreported associa-
tion in this study. We have discussed about theMEFV gene
and PFAPA in a distinct article.51 However, here we report
six FMF patients with co-existed PFAPA. In all of these
patients, MEFV mutations are positive and one of them
had compound heterozygote mutations (R761H-M694I).
In half of these patients, FMF had been developed earlier
than PFAPA.
Initially, we thought these patients are colchicine-
resistant FMF, but more workup and closed observation
with good response to a single dose of prednisolone during
attacks revealed their co-existed PFAPA. On the basis of
this finding particularly in young patients with colchicine
resistant FMF, we recommend the probability of PFAPA as
a possible associated condition.
In a recently published study by Yildiz,52 they showed
that frequency of certain inflammatory conditions such as
juvenile idiopathic arthritis, juvenile spondyloarthropathies,
Henoch–Schönlein purpura, uveitis and inflammatory bowel
disease was increased in their pediatric FMF patients; in
contrary, asthma was less commonly detected in compared
to general prevalence. The results of their study are rela-
tively similar to our findings; however, in our experience
uveitis is not a feature of FMF patients.53
The most important limitation of our study is the lack
of a healthy control group in which we can compare the
frequencies of the diseases. The other limitation was
including adult and pediatric population in the same study.
Conclusion
Associated diseases in FMF usually are presented in
patients with positive MEFV gene mutations particularly
with these five mutations M694V, E148Q, V726A, M680I,
and M694I. Rheumatologic, gastrointestinal and CNS dis-
orders are common co-existed disease.
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